Motiejunaite, Ruta
Ruta Motiejunaite holds a Ph.D. degree in Biochemistry from Vilnius University (Lithuania). She conducted research for her dissertation at the Schepens Eye Research Institute, an affiliate of Harvard Medical School. Her doctoral research was focused on molecular mechanisms of blood vessel stability in the context of neovascular eye diseases such as diabetic retinopathy. Dr. Motiejunaite joined CICS in December of 2013.
Publications
Show
Aranda J, Motiejunaite R, Silva P, Aiello LP, Kazlauskas A
Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy.
Aranda J, Motiejunaite R, Im E, Kazlauskas A
Diabetes disrupts the response of retinal endothelial cells to the angiomodulator lysophosphatidic acid.
Auksorius E, Bromberg Y, Motiejūnaitė R, Pieretti A, Liu L, Coron E, Aranda J, Goldstein AM, Bouma BE, Kazlauskas A, Tearney GJ
Dual-modality fluorescence and full-field optical coherence microscopy for biomedical imaging applications.
Im E, Motiejunaite R, Aranda J, Park EY, Federico L, Kim TI, Clair T, Stracke ML, Smyth S, Kazlauskas A
Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression.
Motiejūnaite R, Kazlauskas A
Pericytes and ocular diseases.
Motiejūnaite R, Armalyte J, Markuckas A, Suziedeliene E
Escherichia coli dinJ-yafQ genes act as a toxin-antitoxin module.
